Target intelligence / Profile preview

U4 small nuclear RNA 16, pseudogene (RNU4-16P)

Target
RNU4-16P
Molecular classification
Other, Non-coding RNA pseudogene
01

Overview

RNU4-16P (RNA, U4 small nuclear 16, pseudogene) is a pseudogene derived from the U4 small nuclear RNA (snRNA) family. It does not encode a functional RNA or protein product. Pseudogenes such as RNU4-16P are generally non-functional genomic sequences closely related to active snRNA genes; they likely arise via mechanisms such as reverse transcription followed by genomic integration. RNU4-16P matches the functional U4 snRNA sequence except at a few positions and is flanked by direct repeats, supporting the hypothesis that it was generated by retrotransposition[1]. Functional U4 snRNA is an essential spliceosomal RNA critical for mRNA splicing, but the pseudogene does not contribute to splicing, has no demonstrated function or disease association, and is not a therapeutic or biomarker target. Important clarification: While U4 snRNA (encoded primarily by the RNU4-2 gene) is an essential and disease-associated non-coding RNA, RNU4-16P is a pseudogene and thus not a functional "target" in the sense of therapeutic targeting, biomarker development, or biological function[1][3][4]. Key points for structured information extraction: - This entry is sometimes misidentified as a functional snRNA or as a gene of interest; any functional or disease relevance is related to active U4 snRNA genes (not the pseudogene)[1][3][4]. - There are no known drugs, biomarkers, or safety issues associated with this pseudogene.

Other names
RNU4-16PRNA, U4 small nuclear 16, pseudogene
02

Biological functions

None for this pseudogene itself
03

Disease associations

None for this pseudogene itself

Beyond the preview

Go deeper on U4 small nuclear RNA 16, pseudogene (RNU4-16P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U4 small nuclear RNA 16, pseudogene (RNU4-16P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call